Evidence map›Paper›PMID 40526785›Full record

ArticleScience signaling2025

Intracellular and nuclear CXCR4 signaling promotes terminal erythroblast differentiation and enucleation.

Julia Christine Gutjahr, Elin Hub, Caroline Amy Anderson, Maryna Samus, Katharina Artinger, Esteban A Gomez, Christoph Ratswohl, Natalie Wickli, Mandy Raum, Neil Dufton and 4 more

Abstract read
In one paragraph

Article in Science signaling, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Blood Pharming of Red Cells.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Julia Christine GutjahrCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.ORCID 0000-0002-9193-8402
Elin HubCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Caroline Amy AndersonCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.ORCID 0000-0002-5483-6909
Maryna SamusCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.
Katharina ArtingerCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.ORCID 0000-0002-5677-3171
Esteban A GomezBiochemical Pharmacology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.ORCID 0000-0001-8028-416X
Christoph RatswohlInstitute of Cell Biology and Immunology Thurgau (BITG), University of Konstanz, Kreuzlingen 8280, Switzerland.ORCID 0000-0001-5413-0730
Natalie WickliInstitute of Cell Biology and Immunology Thurgau (BITG), University of Konstanz, Kreuzlingen 8280, Switzerland.ORCID 0009-0007-9421-4657
Mandy RaumInstitute of Cell Biology and Immunology Thurgau (BITG), University of Konstanz, Kreuzlingen 8280, Switzerland.ORCID 0009-0004-4671-3820
Neil DuftonCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.ORCID 0000-0002-6283-9210
Jesmond DalliBiochemical Pharmacology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.ORCID 0000-0001-6328-3640
Jemima J BurdenLaboratory for Molecular Cell Biology, University College London, London, WC1E 6BT, UK.ORCID 0000-0001-5894-7043
Johan DucheneInstitute for Cardiovascular Prevention, Ludwig-Maximilians University, Munich 80336, Germany.ORCID 0000-0002-3973-0022
Antal RotCentre for Microvascular Research, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.ORCID 0000-0002-9730-6166

Funding

Wellcome Trust
6 · The paper itself

Abstract

The chemokine CXCL12 signals through its receptor CXCR4 to induce the migration of all leukocyte types and multiple other cell types. Here, we report that CXCR4 is expressed in mouse erythroblasts, the bone marrow erythroid precursors, in which it stimulates erythrocyte generation instead of chemotaxis. CXCR4 signaling promoted homeostatic erythroblast maturation and increased the expression of genes mainly involved in metabolism and chromatin organization. Consequently, genetic depletion of CXCR4 in erythroblasts inhibited late erythropoiesis and diminished bone marrow erythroid outputs. Binding of CXCL12 to CXCR4 stimulated its rapid endocytosis and translocation together with Gα

Indexed as

Cell DifferentiationCell NucleusErythroblastsErythropoiesisReceptors, CXCR4Signal TransductionAnimalsChemokine CXCL12EndocytosisMiceMice, Inbred C57BLMice, KnockoutChemokine CXCL12Cxcl12 protein, mouseCXCR4 protein, mouseReceptors, CXCR4

Identifiers

PMID40526785
PMCPMC7619343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.